Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Vaccines for Innate Immune Training in COPD
NCT06257212Phase 4Completed
- Start
- Feb 2024
- Primary completion
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine, measles, mumps, and rubella vaccine in chronic obstructive pulmonary disease (COPD). Started Feb 2024; status: completed.
02
Drugs
bcg vaccinemeasles, mumps, and rubella vaccine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06257212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06257212.